Luteolin (monohydrate)

• UNSPSC Description:

  Luteolin (monohydrate) is the monohydrate of Luteolin. Luteolin (Luteoline), a flavonoid, is also a potent Nrf2 inhibitor. Luteolin has anti-inflammatory and anticancer properties, induces apoptosis and cell cycle arrest in multiple human cancer cell lines, including non-small lung cancer cells, and inhibits cell metastasis and angiogenesis[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/luteolin-monohydrate.html

• Purity:

  99.01

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C=C(C2=CC(O)=C(O)C=C2)OC3=C1C(O)=CC(O)=C3.O

• Molecular Weight:

  304.25

• References & Citations:

  [1]Luo Y, et al. Luteolin cocrystals: Characterization, evaluation of solubility, oral bioavailability and theoretical calculation[J]. Journal of Drug Delivery Science and Technology, 2019, 50: 248-254.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  Phase 1

• CAS Number:

  6113-16-2